Earnings results for Vericel (NASDAQ:VCEL)
Vericel Corporation is expected* to report earnings on 02/24/2021 before market open. The report will be for the fiscal Quarter ending Dec 2020. According to Zacks Investment Research, based on 4 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.21. The reported EPS for the same quarter last year was $0.2.
Analyst Opinion on Vericel (NASDAQ:VCEL)
8 Wall Street analysts have issued ratings and price targets for Vericel in the last 12 months. Their average twelve-month price target is $40.86, predicting that the stock has a possible downside of 20.51%. The high price target for VCEL is $60.00 and the low price target for VCEL is $30.00. There are currently 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus rating of “Buy.”
Vericel has received a consensus rating of Buy. The company’s average rating score is 2.75, and is based on 6 buy ratings, 2 hold ratings, and no sell ratings. According to analysts’ consensus price target of $40.86, Vericel has a forecasted downside of 20.5% from its current price of $51.40. Vericel has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.
Dividend Strength: Vericel (NASDAQ:VCEL)
Vericel does not currently pay a dividend. Vericel does not have a long track record of dividend growth.
Insiders buying/selling: Vericel (NASDAQ:VCEL)
In the past three months, Vericel insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $412,125.00 in company stock. Only 4.30% of the stock of Vericel is held by insiders. 93.11% of the stock of Vericel is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
Earnings and Valuation of Vericel (NASDAQ:VCEL
The P/E ratio of Vericel is -5,140,000.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Vericel is -5,140,000.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Vericel has a P/B Ratio of 20.64. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
More latest stories: here